MSLN and ovarian cancer: It was found later that mesothelin interacted strongly and specifically with the large glycoprotein MUC16, which is highly expressed in ovarian cancer cells [11,12], and that this interaction was mediated by the N-linked oligosaccharides of MUC16[11].